"CXCR2 protein expression was up-regulated in both the epileptic foci of temporal lobe epilepsy patients and in the pilocarpine mouse model. The CXCR2 selective antagonist SB225002 which was i.p. administered during the spontaneous recurrent seizures (SRSs) latency window preceding SRS onset suppressed SRSs activity during the chronic period of epilepsy."xsd:string